Rigel Pharmaceuticals

Recent news

• Rating change
  Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $42
  Market Newswire · 2026/2/6
• Rating change
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $81
  Market Newswire · 2026/5/13
• Rating change
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $83
  Market Newswire · 2026/8/6
• Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $83
  Market Newswire · 2026/8/6
• Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $49
  Market Newswire · 2026/8/17
• Rating change
  Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Cuts Target Price to $40
  Market Newswire · 2026/4/24
• Rating change
  H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57
  Market Newswire · 2026/8/5
• Rating change
  Jefferies Initiates Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Announces Target Price $42
  Market Newswire · 2025/11/6
• Rating change
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $81
  Market Newswire · 2026/5/13
• Rating change
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Cuts Target Price to $69
  Market Newswire · 2026/5/7
• Rating change
  Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $40
  Market Newswire · 2026/5/13
• H.C. Wainwright Sticks to Their Buy Rating for Rigel (RIGL)
  TipRanks · 2026/10/5
• Company notice
  Rigel Pharmaceuticals: Rigel Pharmaceuticals, Inc. - Reverse Split Option Symbol: RIGL New Symbol: RIGL1
  OCC · 2024/6/26
• Rating change
  Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $71
  Market Newswire · 2026/3/4
• Rating change
  Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Maintains Target Price $38
  Market Newswire · 2026/3/4
• H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $85
  Market Newswire · 2026/10/5
• Rating change
  Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $38
  Market Newswire · 2025/11/5
• Rating change
  H.C. Wainwright Reaffirms Their Buy Rating on Rigel (RIGL)
  TipRanks · 2026/1/28
• H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $85
  Market Newswire · 2026/8/14
• Rating change
  Cantor Fitzgerald Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Raises Target Price to $43
  Market Newswire · 2026/8/5

Headlines are aggregated automatically and are not independently verified or edited by our team.